LIFESTYLE NEWS - In South Africa, cervical cancer is the second most common cancer among women between 15 and 44 years of age.
More than 95% of cases of cervical cancer are caused by human papillomavirus (HPV).1 HPV is the most common viral infection of the reproductive tract.
Cervical cancer is the leading cause of cancer death in females between the ages of 15 and 44. While most HPV infections (more than 90%) naturally clear up without causing harm, there remains a real risk of HPV infection leading to cancer.
It's quite alarming to learn that nearly 6 000 women in South Africa lose their lives to cervical cancer each year. Men aren’t immune either and are also at risk of developing penile, throat, and anal cancer due to HPV.
South Africa’s new weapon in its arsenal
HPV vaccines target HPV types 16 and 18, responsible for a whopping 70% of cervical cancers!1 There is a 9 -valent vaccine that offers even wider protection, and now available right here in South Africa.
It is important to note that cervical cancer is not only caused by 16 and 18, but other HPV types are also culprits.3 16 and 18, together with a majority of these other cervical cancer-causing HPV types are included in the 9-valent vaccine.
Zweli Bashman, Managing Director, MSD SA & SSA.
"Our mission with the introduction of the 9-valent HPV vaccine to the South African market re-affirms our commitment to the elimination of HPV. We live in a region with the highest HPV prevalence, highest cervical cancer incidence and accounting for the highest mortality rates in the world.1h This makes it our mission as an innovative medicines company to ensure that we bring the best available vaccines to our market. We are actively and continuously working with all key stakeholders to find ways of expanding access and enhance the protection of individuals, empowering them to lead healthier lives free from the risks of HPV-related diseases.”
The HPV vaccine, preventing 9 HPV types
The 9-valent HPV vaccine offers comprehensive protection against nine types of HPV, including the types most associated with cervical cancer, types 16 and 18 and two low-risk types - 6 and 11.
In comparison to the quadrivalent vaccine, this vaccine goes the extra mile, safeguarding against five other high-risk cancer HPV types (31, 33, 45, 52, and 58).3 With the 9-valent vaccine, you can feel confident not only in preventing cervical cancer but also other HPV-related diseases, including vaginal, vulvar, and anal cancers, as well as genital warts.
Take charge of your health and ensure protection for yourself, your loved ones, and your family. With the 9-valent HPV vaccine, you're making a smart choice for your health. Speak to your local pharmacist, clinic nursing sister or doctor about HPV vaccination and safeguard your future.
Choosing the right protection
The 9-valent HPV vaccine targets nine types of HPV.
- High-risk types 16 and 184
- Low-risk types 6 and 11, causing genital warts 4
- Five other high-risk types (31, 33, 45, 52, and 58)4
The Quadrivalent HPV vaccine 4a targets four types of HPV.
- High-risk types 16 and 184
- Low risk types 6 and 11, causing genital warts4
People living with HIV are 6 times more likely to get cervical cancer1
An astonishing 85% of women diagnosed with cervical cancer and HIV live in sub-Saharan Africa.5 This statistic highlights the significant impact of HIV on the prevalence of cervical cancer within our country.
People living with HIV are six times more likely to get cervical cancer1, emphasising the importance of HPV vaccination. HIV has an indirect role in oncogenesis, mainly via immune suppression, enhancing the effects of high-risk HPV.
When it comes to countries like South Africa, where we deal with the dual challenge of high cervical cancer rates and HIV prevalence, prioritising HPV vaccination becomes paramount.5 HPV vaccines can make a huge difference in preventing cervical cancer and reducing the burden of disease in the long run.
HPV vaccination made easy
Accessing the HPV vaccines is convenient and hassle-free. The HPV vaccine does not require a prescription, making it easily obtainable. Healthcare providers across South Africa offer vaccination services, allowing you to schedule an appointment and receive the vaccine during routine healthcare visits. Speak to your doctor, clinic nursing sister or local pharmacist to learn more.
Taking proactive steps towards your health has never been simpler.
Don’t wait, vaccinate
Getting vaccinated before being exposed to HPV is highly recommended before being exposed to the virus.1 The optimal time would be usually between the ages of 9 and 14 years.
The good news is that the 9-valent vaccine is approved for both males and females up to the age of 45 years old.
By vaccinating everyone, we can further reduce the overall burden of HPV-related cancers and safeguard the health of our communities.1 Protect your family against HPV.
Dr. Trudy Smith is a Gynaecological oncologist at Wits Donald Gordon Medical Centre
"Cervical cancer is the most common cancer in women aged 15 to 44 years in South Africa and it is second leading cause of female cancer in South Africa. 2 The HPV vaccine is cancer preventing. Therefore, we must as a country make it our mission to ensure that women get vaccinated and protected against cervical cancer” 1
Scientific backing of HPV vaccination
Extensive research and clinical trials over 15 years has shown that all HPV vaccines are safe.6 The protection provided by HPV vaccines is durable, lasting at least about 12 years.6 The 9-valent vaccine has received endorsement from Health Care Professions in the field due to its proven efficacy. 4
Speak to your doctor, clinic nursing sister or local pharmacist about the HPV vaccine. You can also visit https://medinformer.co.za/ for additional insights on HPV. Don't wait, prioritize your health, your families’ health, and take the necessary steps towards prevention.
Some key facts about the newly available 9valent HPV vaccine
- Comprehensive protection: the 9-valent vaccine provides protection against nine types of HPV, including those associated with cervical cancer and other HPV-related diseases.
- Preventive Benefits: The 9-valent vaccine is highly effective in preventing cervical cancer, as well as other HPV-related diseases such as vaginal, vulvar, anal cancers, and genital warts.
- Convenience and Accessibility: The 9-valent vaccine does not require a prescription, making it easily obtainable during your routine healthcare visits.
- Gender-Neutral Vaccine: Approved for both males and females, the nonavalent vaccine recognizes the impact of HPV on both sexes, reducing the overall burden of HPV-related diseases.
- Early Vaccination is Key: Vaccinating preteens and young adults between the ages of 9 and 14 years old provides optimal protection and the best defense against HPV-related diseases. Vaccination starts from 9 years onwards for both men and women.
- Safety Profile: Extensively tested in clinical trials, the nonavalent vaccine has been proven safe and well-tolerated.
- Long-Lasting Protection: The nonavalent vaccine offers durable immunity for at least 12 years, providing long-term protection against HPV-related diseases.
- Strong Scientific Support: The nonavalent vaccine is supported by extensive research, approved by regulatory authorities worldwide, and recommended by major health organizations for the prevention of HPV-related diseases.
‘We bring you the latest Garden Route, Hessequa, Karoo news’
